Please assess the completion status of the following clinical trial:

Trial Title: Effect of Topical Dexmedetomidine on Intraocular Pressure

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients with healthy eyes and no history of glaucoma~Exclusion Criteria:~* history of glaucoma, IOP \> 24mmHg at baseline, abnormal optic nerve on fundus examination, keratoconus, corneal graft, corneal edema or a history of refractive surgery

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- BSS (Type: SHAM_COMPARATOR): Balanced salt solution
- Dexmedetomidine (Type: ACTIVE_COMPARATOR): dexmedetomidine (0.0055%)

Based on this trial design, predict the completion outcome and termination type (if applicable).